Health and Me on MSN
Could GLP-1 drugs help prevent rupture of abdominal aortic aneurysm? Study finds 46% reduction in risk
A recent study in the Journal of Vascular Surgery found that aortic aneurysm rupture was recorded in about 1.6% of people ...
The intravenous delivery of immune-modulating cells may someday slow the expansion of bulges in the aorta, known as abdominal aortic aneurysms. A second study found evidence that a COVID-19 infection ...
A small number of potentially game-changing trials in Europe and around the world could be on the verge of identifying, for the first time, a medical treatment to prevent the progression of abdominal ...
When the artery that supplies the stomach and the liver forms a bulge that ruptures, this medical emergency results in the deaths of 50 percent of patients before they reach the hospital. This "silent ...
A study of 27,444 matched patients links GLP-1 drugs to 46% lower adjusted aortic aneurysm rupture risk, though clinical ...
An abdominal aortic aneurysm (AAA or “triple A”) is a potentially life-threatening condition where the aorta, which is the body’s main artery, becomes enlarged in the abdomen. This condition can be ...
The first potential drug treatment for abdominal aortic aneurysms (AAA) may be on the horizon, thanks to research led in the UK by the University of Leicester and part-funded by the British Heart ...
Intermittent hypoxia caused by obstructive sleep apnea increased the susceptibility of mice to develop abdominal aortic aneurysms, researchers report in a new study. Obstructive sleep apnea may be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results